Similar articles

• [The pill and cancer].

  Rabe T, Runnebaum B. Rabe T, et al. Ther Umsch. 1986 May;43(5):372-87. Ther Umsch. 1986. PMID: 3523814 Review. German. No abstract available.
• [Ovulation inhibitors and tumors].

  Freundl G, Brossmann H. Freundl G, et al. Dtsch Med Wochenschr. 1985 Aug 30;110(35):1346-50. doi: 10.1055/s-2008-1069009. Dtsch Med Wochenschr. 1985. PMID: 3896722 Review. German. No abstract available.
• [Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology].

  Hammerstein J, Bolt HM, Breckwoldt M, von Eickstedt KW, Elger W, Hoffmann B, Köbberling J, Knorr D, Nieschlag E, Nocke W, et al. Hammerstein J, et al. Dtsch Med Wochenschr. 1987 May 29;112(22):897-9. Dtsch Med Wochenschr. 1987. PMID: 3034544 German. No abstract available.
• Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers.

  Prentice RL. Prentice RL. Prev Med. 1991 Jan;20(1):38-46. doi: 10.1016/0091-7435(91)90005-o. Prev Med. 1991. PMID: 1848935 Review.
• Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?

  Olsson H. Olsson H. Med Oncol Tumor Pharmacother. 1990;7(1):61-4. doi: 10.1007/BF03000492. Med Oncol Tumor Pharmacother. 1990. PMID: 2187124 Review. No abstract available.